Riskpilot← Back to searchSign inGet full accessInnomedi Oy
OYDissolvedY-tunnus 2704595-4Pellervontie 7Wholesale of other food · NACE 4638Est. 2015— employees
Revenue 2025
EUR 14K
-69% vs 2024
EBITDA margin
48.4%
-93% vs 2024
Equity ratio
99.1%
Financial strength
Net profit 2025
EUR 12K
+2840% vs 2024
| Revenue | EUR 14K | -69% |
| EBITDA | EUR 7K | -93% |
| Net profit | EUR 12K | +2840% |
| Total assets | EUR 530K | -6% |
| Equity | EUR 525K | -6% |
| Employees | — | — |
Legal name
Innomedi Oy
Y-tunnus number
2704595-4
Legal form
Osakeyhtiö
NACE code
4638 · Wholesale of other food
Founded
14. elokuuta 2015
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveystuotteiden, lääkkeiden käyttöön tarvittavien välineiden ja tarvikkeiden, nikotiinivalmisteiden, luontaistuotteiden, elintarvikkeiden ja kosmeettisten valmisteiden ja muiden ns. vapaankaupan tuotteiden vähittäiskauppa, tukku kauppa, valmistus, maahantuonti ja maastavienti. Yhtiön toimialaan kuuluvat myös lääkehoidon tukipalvelut, kosmetologin palvelut, konsultointi -ja koulutuspalvelut ja henkilöstönvuokraus. Lisäksi yhtiön toimialaan kuuluvat kiinteistöjen ja maa-alueiden, osuuksien, osakkeiden ja muiden arvopapereiden ostaminen, hallitseminen ja myyminen.
Address
Pellervontie 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 537 | 518 | 501 | 46 | 14 |
| Staff expenses | −0 | 0 | 0 | — | — |
| EBITDA | 137 | 910 | 875 | 100 | 7 |
| Depreciation & amort. | −9 | 8 | 8 | 6 | −6 |
| EBIT | 128 | 118 | 118 | −4 | 1 |
| Net financials | −1 | −5 | 2 | −4 | 8 |
| Profit before tax | 127 | 113 | 139 | 1 | 14 |
| Tax | 26 | 29 | 23 | 0 | −2 |
| Net profit | 100 | 84 | 117 | 0 | 12 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 732 | 691 | 630 | 562 | 530 |
| Equity | 488 | 533 | 606 | 559 | 525 |
| Long-term debt | 132 | 84 | 0 | — | — |
| Short-term debt | 112 | 74 | 23 | 3 | 5 |
| Total debt | 244 | 158 | 23 | 3 | 5 |
EBITDA margin
48.4%
This company
15.8%
Market median
+206% vs market
20212025
Equity ratio
99.1%
This company
38.2%
Market median
+159% vs market
20212025
Return on equity
2.3%
This company
18.4%
Market median
-88% vs market
20212025
Net profit margin
83.8%
This company
8.1%
Market median
+935% vs market
20212025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
JP Deputy Member | Deputy Member | 2015 |
LK Chief Executive Officer | Chief Executive Officer | 2015 |
JB Audit | Audit | 2019 |
TT Deputy auditor | Deputy auditor | 2019 |
| Former (1) | ||
PJ | Audit | 2015 – 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Innomedi Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Juha Pekka Puustjärvi | Deputy Member | 0 companies |
| Leena Kristiina Puustjärvi | Chief Executive Officer | 0 companies |
| Pekka Johannes Neuvonen | Audit | 0 companies |
| Jan-Erik Björklöf | Audit | 0 companies |
| Timo Tapio Post | Deputy auditor | 0 companies |